Zhejiang Tailin BioEngineering Co.,Ltd (SHE:300813)
China · Delayed Price · Currency is CNY 30.48
+1.51 (5.21%)
Apr 1, 2026, 3:04 PM CST
SHE:300813 Revenue
In the year 2025, Zhejiang Tailin BioEngineering Co.,Ltd had annual revenue of 339.54M CNY, down -2.71%. Zhejiang Tailin BioEngineering Co.,Ltd had revenue of 126.35M in the quarter ending December 31, 2025, with 18.60% growth.
Revenue
339.54M
Revenue Growth
-2.71%
P/S Ratio
10.77
Revenue / Employee
426.02K
Employees
797
Market Cap
3.66B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 339.54M | -9.46M | -2.71% |
| Dec 31, 2024 | 349.00M | 79.14M | 29.33% |
| Dec 31, 2023 | 269.86M | -104.02M | -27.82% |
| Jan 1, 2023 | 373.88M | 90.63M | 32.00% |
| Jan 1, 2022 | 283.25M | 83.01M | 41.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shanghai Kehua Bio-Engineering Co.,Ltd | 1.60B |
| Guangdong Biolight Meditech | 1.05B |
| Ningbo David Medical Device | 516.76M |
| Dirui Industrial | 511.11M |
| Chison Medical Technologies | 447.35M |
| Nanjing Medlander Medical Technology | 431.59M |
| Wuhan Easy Diagnosis Biomedicine | 351.25M |
| Beijing Leadman Biochemistry | 326.31M |